Skip to main content
H.R. 2339 116th Congress House

Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020

Official title: To amend the Federal Food, Drug, and Cosmetic Act with respect to the sale and marketing of tobacco products, and for other purposes.

Introduced: July 9, 2019 Introduced by: Frank Pallone, Jr. Democratic · New Jersey See on congress.gov
Health Administrative law and regulatory proceduresCancerCardiovascular and respiratory healthChild health
More subjectsShow fewer subjects
Civil actions and liabilityCongressional oversightConsumer affairsDepartment of Health and Human ServicesDigestive and metabolic diseasesDrug safety, medical device, and laboratory regulationDrug, alcohol, tobacco useFood and Drug Administration (FDA)Government information and archivesGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessHealth facilities and institutionsHealth information and medical recordsHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesMarketing and advertisingMedical researchMedical tests and diagnostic methodsMedicareMental healthMinority healthRacial and ethnic relationsResearch administration and fundingRetail and wholesale tradesSales and excise taxesState and local courtsState and local government operationsUser charges and fees
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 25 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 2, 2020
Received in the Senate and Read twice and referred to the Committee on Finance.
Feb 28, 2020
Mr. Walden moved to recommit with instructions to the Committee on Energy and Commerce. (text: CR H1286-1287)
Feb 28, 2020
Motion to reconsider laid on the table Agreed to without objection.
Feb 28, 2020
On passage Passed by the Yeas and Nays: 213 - 195 (Roll no. 78). (text: CR H1257-1262)
Feb 28, 2020
On motion to recommit with instructions Failed by the Yeas and Nays: 187 - 220 (Roll no. 77).
Feb 28, 2020
The previous question on the motion to recommit with instructions was ordered without objection.
Feb 28, 2020
Floor summary: DEBATE - The House proceeded with 10 minutes of debate on the Walden motion to recommit with instructions. The instructions contained in the motion seek to require the bill to be reported back to the House with an amendment to insert a new title at the end of the bill, "Born-Alive Abortion Survivors Protection."
Feb 28, 2020
Considered as unfinished business. (consideration: CR H1286-1289)
Feb 28, 2020
POSTPONED PROCEEDINGS - Pursuant to clause 1(c) of Rule XIX, further proceedings on H.R. 2339 were postponed.
Feb 28, 2020
The previous question was ordered pursuant to the rule.
Feb 28, 2020
DEBATE - The House proceeded with 90 minutes of debate on H.R. 2339.
Feb 28, 2020
Rule provides for consideration of H.R. 2339 with 1 hour and 30 minutes of general debate. Motion to recommit with or without instructions allowed.
Feb 28, 2020
Considered under the provisions of rule H. Res. 866. (consideration: CR H1257-1286)
Feb 27, 2020
Rule H. Res. 866 passed House.
Feb 26, 2020
Rules Committee Resolution H. Res. 866 Reported to House. Rule provides for consideration of H.R. 2339 with 1 hour and 30 minutes of general debate. Motion to recommit with or without instructions allowed.
Feb 21, 2020
Placed on the Union Calendar, Calendar No. 324.
Feb 21, 2020
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-402.
Nov 19, 2019
Ordered to be Reported (Amended) by the Yeas and Nays: 28 - 24.
Nov 19, 2019
Committee Consideration and Mark-up Session Held.
Nov 13, 2019
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Nov 13, 2019
Subcommittee Consideration and Mark-up Session Held.
Oct 16, 2019
Subcommittee Hearings Held.
Apr 19, 2019
Referred to the Subcommittee on Health.
Apr 18, 2019
Introduced in House
Apr 18, 2019
Referred to the House Committee on Energy and Commerce.
 Votes taken on this bill 2
DateChamberWhat was voted onResultYes–No
Feb 28, 2020 House · vote #78 On Passage Passed 213–195 See who voted →
Feb 28, 2020 House · vote #77 On Motion to Recommit with Instructions Failed 187–220 See who voted →
 Amendments to this bill 1

Amendments propose changes to this bill. Members vote on amendments separately before the final bill vote. An agreed amendment becomes part of the bill; a failed amendment does not.

1 agreed to

AmendmentSponsorPurposeStatusLatest action
HAMDT 802 – Pursuant to the provisions of H.Res. 866, an amendment in the nature of a substitute consisting of the text o… Agreed to Feb 28, 2020
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action March 2, 2020

Received in the Senate and Read twice and referred to the Committee on Finance.

 Plain-English summary Congressional Research Service

Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020

This bill revises requirements related to the safety, sale, and advertisement of tobacco products, including electronic nicotine delivery systems (e.g., e-cigarettes, e-hookah, e-cigars, and vape pens).

Among other requirements, the bill

  • requires the Food and Drug Administration (FDA) to implement regulations to require color graphics on the labeling of cigarette packages, depicting the negative health consequences of smoking;
  • requires the FDA to apply regulations on tobacco products to all tobacco products, including e-cigarettes;
  • generally prohibits the retail online sale of tobacco products, including electronic nicotine delivery systems;
  • prohibits flavors other than tobacco in a tobacco product;
  • prohibits the use of flavored products in an electronic nicotine delivery system, except in specified circumstances;
  • increases the user fees that the FDA collects from manufacturers and importers;
  • directs the FDA to regulate products containing nicotine not made or derived from tobacco plants (including nicotine from chemical synthesis, recombinant genetic technology, or extraction from non-tobacco plants);
  • imposes an excise tax on nicotine that has been extracted, concentrated, or synthesized;
  • provides funding through FY2025 to support public education regarding tobacco regulation, public awareness regarding the harms associated with tobacco use, outreach to medically underserved communities regarding tobacco-use prevention and cessation, research grants related to tobacco-use prevention and cessation, and grants to health centers for tobacco-use cessation treatment;
  • establishes and provides funding through FY2025 for a demonstration grant program to develop strategies for smoking cessation (including of the use of menthol-flavored tobacco products) in medically underserved communities;
  • beginning in 2024, waives coinsurance under Medicare for colorectal-cancer screening tests;
  • specifies that a health insurance plan may still be treated, for certain tax-deduction purposes, as a high-deductible plan even if it does not have a deductible for certain inhalers or nebulizers; 
  • exempts certain cigars from premarket review requirements;
  • increases civil penalties for certain violations of restrictions on the sale of tobacco products; and
  • requires the Government Accountability Office to study e-cigarettes.   
 Related & companion bills 6
  • HRES 866 Procedurally related Providing for consideration of the bill (H.R. 2339) to amend the Federal Food, Drug, and Cosmetic Act with respect to t…
  • S 3174 Reversing the Youth Tobacco Epidemic Act of 2020
  • HR 4716 I CAN Act
  • HR 4742 Protecting American Lungs Act of 2019
  • S 3223 Resources to Prevent Youth Vaping Act
  • HR 1570 Removing Barriers to Colorectal Cancer Screening Act of 2020
 Bill text 4 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Cosponsors 98
All 98 Democratic 75 Republican 1
CLAY, WM.
· Feb 21, 2020
 R
Fitzpatrick, Brian K.
Pennsylvania · Feb 21, 2020
 D
Larson, John B.
Connecticut · Feb 21, 2020
Levin, Andy
· Feb 21, 2020
 D
Vargas, Juan
California · Feb 21, 2020
 D
Thompson, Mike
California · Feb 18, 2020
 D
Gomez, Jimmy
California · Feb 13, 2020
 D
Waters, Maxine
California · Feb 11, 2020
 D
Carson, André
Indiana · Feb 6, 2020
 D
Garcia, Sylvia R.
Texas · Feb 4, 2020
 D
Nadler, Jerrold
New York · Jan 30, 2020
Rice, Kathleen
· Jan 30, 2020
 D
McBath, Lucy
Georgia · Jan 28, 2020
 D
Jeffries, Hakeem S.
New York · Jan 24, 2020
Maloney, Sean
· Jan 24, 2020
 D
Slotkin, Elissa
Michigan · Jan 21, 2020
SERRANO, JOSE
· Jan 15, 2020
 D
Espaillat, Adriano
New York · Jan 13, 2020
 D
Bonamici, Suzanne
Oregon · Jan 7, 2020
 D
Beatty, Joyce
Ohio · Dec 23, 2019
Speier, Jackie
· Dec 23, 2019
 D
Castro, Joaquin
Texas · Dec 11, 2019
 D
Evans, Dwight
Pennsylvania · Dec 6, 2019
 D
Sánchez, Linda T.
California · Dec 5, 2019
 D
Casten, Sean
Illinois · Dec 3, 2019
Malinowski, Tom
· Nov 26, 2019
 D
Lofgren, Zoe
California · Nov 13, 2019
 D
Moore, Gwen
Wisconsin · Nov 13, 2019
 D
Scanlon, Mary Gay
Pennsylvania · Nov 13, 2019
 D
Chu, Judy
California · Nov 12, 2019
 D
Dean, Madeleine
Pennsylvania · Nov 12, 2019
 D
García, Jesús G. "Chuy"
Illinois · Nov 1, 2019
 D
Soto, Darren
Florida · Nov 1, 2019
 D
Luján, Ben Ray
New Mexico · Oct 30, 2019
McNerney, Jerry
· Oct 30, 2019
 D
Bera, Ami
California · Oct 28, 2019
 D
DeSaulnier, Mark
California · Oct 28, 2019
 D
Houlahan, Chrissy
Pennsylvania · Oct 28, 2019
 D
Khanna, Ro
California · Oct 28, 2019
Lawrence, Brenda
· Oct 28, 2019
 D
Takano, Mark
California · Oct 28, 2019
Demings, Val
· Oct 21, 2019
 D
Huffman, Jared
California · Oct 21, 2019
 D
Matsui, Doris O.
California · Oct 21, 2019
 D
Ruiz, Raul
California · Oct 21, 2019
 D
Case, Ed
Hawaii · Oct 11, 2019
 D
Hayes, Jahana
Connecticut · Oct 11, 2019
LANGEVIN, JAMES
· Oct 11, 2019
 D
Norcross, Donald
New Jersey · Oct 11, 2019
 D
Kelly, Robin L.
Illinois · Oct 8, 2019
Page 1 of 2 Next
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2339: Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-HR-2339/
MLA
"H.R. 2339: Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-2339/.
Bluebook (legal)
H.R. 2339, 116th Cong. (2026), https://openamerica.io/bill/116-HR-2339/.
Markdown link
[H.R. 2339: Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020](https://openamerica.io/bill/116-HR-2339/)
Report a problem